Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HIF1A | Q16665 | 3/20 | 0.53 |
| ▸ | EPAS1 | Q99814 | 3/20 | 0.53 |
| ▸ | GPR84 | Q9NQS5 | 13/20 | 0.50 |
| ▸ | MAPT | P10636 | 1/20 | 0.42 |
| ▸ | HTT | P42858 | 1/20 | 0.42 |
| ▸ | CTSV | O60911 | 1/20 | 0.40 |
| ▸ | CTSL | P07711 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL826339 | 0.92 | HIF1A (0.43) | HIF1AEPAS1GPR84MAPTHTT | |
| SCHEMBL890821 | 0.82 | HIF1A (0.66) | HIF1AEPAS1GPR84MAPTHTT | |
| SCHEMBL891143 | 0.82 | HIF1A (0.66) | HIF1AEPAS1GPR84MAPTHTT | |
| SCHEMBL17156491 | 0.82 | HIF1A (0.66) | HIF1AEPAS1GPR84MAPTHTT | |
| SCHEMBL891349 | 0.82 | HIF1A (0.66) | HIF1AEPAS1GPR84MAPTHTT | |
| SCHEMBL490816 | 0.80 | HIF1A (0.62) | HIF1AEPAS1GPR84MAPTHTT | |
| SCHEMBL499037 | 0.79 | HIF1A (0.36) | HIF1AEPAS1MAPTHTT | |
| SCHEMBL17156498 | 0.78 | HIF1A (0.60) | HIF1AEPAS1GPR84MAPTHTT | |
| SCHEMBL18016845 | 0.75 | HIF1A (0.58) | HIF1AEPAS1GPR84MAPTHTT | |
| SCHEMBL11391651 | 0.74 | MAPT (0.46) | HIF1AEPAS1GPR84MAPTHTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200384451-A1 | PHOSPHINE FREE COBALT BASED CATALYST, PROCESS FOR PREPARATION AND USE THEREOF | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) | 2020-12-10 | — | — | US | claimed |
| US-20200384451-A1 | PHOSPHINE FREE COBALT BASED CATALYST, PROCESS FOR PREPARATION AND USE THEREOF | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) | 2020-12-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200384451-A1 | PHOSPHINE FREE COBALT BASED CATALYST, PROCESS FOR PREPARATION AND USE THEREOF | CPNE4, PPOX, PDCD5 | HIF1A 1674/4885EPAS1 4711/4885GPR84 3545/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.